Indian drug maker Sun clinches Ranbaxy in US$4b deal

Indian drug giant Sun Pharmaceutical Industries said it agreed to buy its troubled peer Ranbaxy for US$4 billion in stock, ending its ill-fated six-...



via The Standard - Breaking News http://ift.tt/1jnd380